Muscle-specific deletion of SOCS3 increases the early inflammatory response but does not affect regeneration after myotoxic injury by Kristy Swiderski et al.
RESEARCH Open Access
Muscle-specific deletion of SOCS3 increases
the early inflammatory response but does
not affect regeneration after myotoxic
injury
Kristy Swiderski, Savant S. Thakur, Timur Naim, Jennifer Trieu, Annabel Chee, David I. Stapleton,
René Koopman and Gordon S. Lynch*
Abstract
Background: Muscles of old animals are injured more easily and regenerate poorly, attributed in part to increased
levels of circulating pro-inflammatory cytokines. The Janus kinase/signal transducers and activators of transcription
(JAK/STAT) signaling cascade is a key mediator of inflammatory cytokine action, and signaling via this pathway is
increased in muscles with aging. As a negative regulator of JAK/STAT signaling, a key mediator of myogenic
proliferation and differentiation, altered expression of suppressor of cytokine signaling (SOCS3) is likely to have
important consequences for muscle regeneration. To model this scenario, we investigated the effect of SOCS3
deletion within mature muscle fibers on injury and repair. We tested the hypothesis that reduced SOCS3 function
would alter the inflammatory response and impair muscle regeneration after myotoxic injury.
Methods: Mice with a specific deletion of SOCS3 within mature skeletal muscle fibers were used to assess the
effect of SOCS3 deletion on muscle injury and repair. Twelve-week-old or 24-month-old SOCS3 muscle-specific
knockout (SOCS3 MKO) mice and littermate controls were either left uninjured or injured with a single injection of
notexin (10 μg/ml) into the right tibialis anterior (TA) muscle. At 1, 2, 3, 5, 7, or 14 days post-injury, the right TA
muscle was excised and subjected to histological, western immunoblotting, and gene expression analyses. Force
production and fatigue were assessed in uninjured muscles and at 7 days post-notexin injury.
Results: In uninjured muscles, SOCS3 deletion decreased force production during fatigue but had no effect on the
gross or histological appearance of the TA muscles. After notexin injury, deletion of SOCS3 increased STAT3
phosphorylation at day 1 and increased the mRNA expression of the inflammatory cytokine TNF-α, and the
inflammatory cell markers F4/80 and CD68 at day 2. Gene expression analysis of the regeneration markers
Pax7, MyoD, and Myogenin indicated SOCS3 deletion had no effect on the progression of muscle repair after
notexin injury. Inflammation and regeneration were also unchanged in the muscles of 24-month-old SOCS3
MKO mice compared with control.
Conclusions: Loss of SOCS3 expression in mature muscle fibers increased the inflammatory response to myotoxic
injury but did not impair muscle regeneration in either adult or old mice. Therefore, reduced SOCS3 expression in
muscle fibers is unlikely to underlie impaired muscle regeneration. Further investigation into the role of SOCS3 in other
cell types involved in muscle repair is warranted.
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Background
Muscles of old animals are more susceptible to injury
and regenerate poorly. Cycles of repeated damage and
incomplete repair contributes to muscle atrophy and
weakness with age [1–5]. A well-regulated inflammatory
response is critical for the initiation of muscle repair
through muscle stem cell activation and necessary for
myogenic differentiation [6–11]. In contrast, chronic
low-grade systemic inflammation is thought to interfere
with effective regeneration in older individuals. Although
increased levels of circulating pro-inflammatory cyto-
kines, such as interleukin −6 (IL-6), interferon-γ (IFN-γ),
and tumor necrosis factor-α (TNF-α) are associated with
muscle wasting and are increased in aged muscle [12],
the signaling mechanisms controlling degeneration,
regeneration, and inflammation are not well understood.
Inflammatory cytokines exert many effects via activation
of the Janus kinase/Signal transducers and activators of
transcription (JAK/STAT) signaling pathway [13]. The
suppressors of cytokine signaling (SOCS) protein family
consisting of eight members including cytokine-induced
STAT inhibitor (CIS) and SOCS1-7 are key negative regu-
lators of JAK/STAT signaling. SOCS3 is one of the best
characterized SOCS proteins and an important regulator
of JAK1/STAT3 signaling and inflammation in many cell
types via direct interactions with both the gp130 receptor
and JAK1 [14–17]. Properly regulated JAK/STAT signaling
is required for progression through myogenic differenti-
ation and critical for muscle regeneration [18].
In the absence of inflammation, SOCS3 is expressed at
very low levels but is thought to play a role in various
muscle resident cells including hematopoietic cells,
muscle stem cells, and mature muscle fibers [17, 19–23].
In vitro adenoviral overexpression of SOCS3 in human
myotubes indicated a role for SOCS3 in directing the
expression of genes regulating myogenic differentiation,
myotube maturation, and cell survival [24], demonstrating
a potential role for SOCS3 in regulating myogenesis.
Transgenic muscle-specific overexpression of SOCS3,
driven by the myosin light chain (MLC) promoter, impairs
muscle morphology and ambulation, associated with
disrupted calcineurin signaling and defects in sarcoplas-
mic reticulum and mitochondrial function [25]. In another
study, transgenic overexpression of SOCS3 driven by the
muscle creatine kinase (MCK) promoter impaired glucose
and insulin tolerance as a result of suppressed leptin-
induced activation of the AMP-regulated protein kinase
(AMPK) [23]. In contrast, mice with MCK-Cre-mediated
SOCS3 deletion had normal muscle development and
functional performance and, consistent with a role of
SOCS3 in inhibition of insulin signaling, had improved
insulin sensitivity and glucose homeostasis [26].
As JAK/STAT signaling is implicated in the regulation
of inflammation, anabolic signaling, and myogenic
differentiation, altered regulation of this signaling is likely
to have important consequences for muscle health and
effective regeneration. Increased STAT3 phosphorylation
and SOCS3 messenger RNA (mRNA) expression has been
reported in skeletal muscles from old compared with
young rats [27]. SOCS3 gene and protein levels were
increased in human skeletal muscle biopsies obtained
from older participants (70 ± 0.3 years) compared to
healthy young adults (20 ± 0.2 years) at rest [28]. However,
in a different study, STAT3 activation was increased and
SOCS3 protein decreased in skeletal muscle biopsies
obtained from older adults compared with younger adults
2 h after a bout of resistance exercise [29]. Interestingly,
mRNA levels of SOCS3 were higher in skeletal muscle
biopsies obtained from older adults compared with young
adults at this time, indicating either an issue with SOCS3
protein translation or a delay in the signaling pathway in
muscles from older adults [29].
Studies testing the hypothesis that altered SOCS3
expression and inflammatory JAK/STAT signaling contrib-
utes to impaired muscle regeneration have produced
conflicting results, but a common theme is an age-related
increase in STAT3 signaling in skeletal muscle which
suggests impaired negative regulation of JAK/STAT signal-
ing by SOCS3 [27, 29]. Reduced SOCS3 function could
contribute to impaired muscle regeneration and chronic
inflammation with aging. To model this scenario, we
investigated the effect of SOCS3 deletion, specifically
within mature muscle fibers, on injury and repair. Since
SOCS3 is expressed in multiple cell types involved in the
repair of muscle after injury (including muscle fibers, stem
cells, and inflammatory cells), it is important to determine
in which cell population reduced SOCS3 expression con-
tributes to impaired muscle regeneration. We tested the
hypothesis that reduced SOCS3 function would alter the




C2C12 cells (obtained from ATCC, Manassas, VA, USA)
were maintained as proliferating myoblasts in culture at
37 °C + 5 % CO2 in DMEM/10 % FBS/1 % L-glutamine
and sub-cultured at 60–70 % confluency. For treatment
of proliferating myoblasts, C2C12 cells were seeded into
six-well tissue culture plates and grown to 50–70 % con-
fluency over 48 h. Cells were either left unstimulated (0)
or stimulated with 100 ng/mL recombinant murine (rm)
IL-6 (kindly provided by Prof. Warren Alexander, The
Walter and Eliza Hall Institute, Melbourne, Australia),
100 ng/mL rm IFN-γ (R&D Systems Inc., MN, USA), or
10 ng/mL rm TNF-α (R&D Systems Inc.) in DMEM/
10 % FBS/1 % L-glutamine for 0.25, 0.5, 1, 2, or 4 h at
37 °C ± 5 % CO2. For treatment of differentiated
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myotubes, C2C12 cells were seeded into six-well tissue
culture plates and grown to 100 % confluency over 48 h
at 37 °C ± 5 % CO2 in DMEM/10 % FBS/1 % L-glutam-
ine. Once confluent, media were replaced with DMEM/
2 % HS/1 % L-glutamine to induce myotube differen-
tiation. Media were changed every 48 h. On day 5 of
differentiation, cells were either left unstimulated (0)
or stimulated with 100 ng/mL rm IL-6, 100 ng/mL
rm IFN-γ, or 10 ng/mL rm TNF-α in DMEM/2 %
HS/1 % L-glutamine for 0.25, 0.5, 1, 2, or 4 h at 37 °
C ± 5 % CO2. Fresh cell culture media was not added
on the day of stimulation to avoid activation of
signaling pathways via addition of fresh serum.
Animals
SOCS3fl/fl MCK-Cre mice were obtained from Prof.
Gregory Steinberg (St Vincent’s Institute, Melbourne,
Australia) and bred and maintained in the Biological
Research Facility (BRF) at The University of Melbourne.
Breeding was performed to generate animals heterozygous
for Cre-recombinase expression (SOCS3fl/fl MCK-Cre+
mice) and Cre-negative littermate controls (SOCS3fl/fl
MCK-Cre− mice). All experimental protocols were
approved by the Animal Ethics Committee of The
University of Melbourne and conducted in accordance
with the Australian code of practice for the care and use
of animals for scientific purposes as stipulated by the
National Health and Medical Research Council (Australia).
To confirm SOCS3 gene deletion by genomic PCR, DNA
was extracted from liver and skeletal muscle tissue from
SOCS3fl/fl MCK-Cre+ and SOCS3fl/fl MCK-Cre− mice using
the GenElute genomic DNA miniprep (Sigma-Aldrich, St.
Louis, MO, USA) as per manufacturer’s instructions.
Genomic PCR was performed using the following forward
and reverse primer sequences: SOCS3, 5′-ACGTCTGTG
ATGCTTTGCTG-3′ and 5′-TCTTGTGTCTCTCCCCA
TCC-3′, under the following conditions: step 1—94 °C
3 min, step 2—94 °C 30 s, step 3—55 °C 30 s, step 4—72 °C
60 s, cycle steps 2–4 36 times, step 5—72 °C 5 min.
To confirm SOCS3 deletion in muscle fibers, SOCS3fl/fl
MCK-Cre+ and SOCS3fl/fl MCK-Cre− mice received an
intraperitoneal injection (i.p.) of saline or lipopolysaccharide
(LPS 1 mg/kg; Sigma-Aldrich) and were killed 4 h post-
injection. Gastrocnemius muscles were removed and snap
frozen. Muscles were freeze-dried overnight and freed from
visible adipose and connective tissue, and individual muscle
fibers were dissected and placed into clean Eppendorf
tubes. Total RNA was extracted using an RNeasy Fibrous
Tissue Mini Kit (Qiagen, Venlo, Limburg, Netherlands) as
per manufacturer’s instructions. The concentration and
quality of RNA samples were determined using Nanodrop
2000 spectrophotometer (Thermo Scientific, Waltham,
MA, USA). Real-time RT-PCR was performed as described
previously [30] using the following forward and reverse
primer sequences: SOCS3, 5′-GCTGGCCAAAGAAATA
ACCA-3′ and 5′- AGCTCACCAGCCTCATCTGT-3′.
Relative gene expression was calculated using the expres-
sion 2−ΔCT, normalized to total complementary DNA
(cDNA) content as determined using Qubit 2.0 Fluorometer
(Life Technologies, Carlsbad, CA, USA), as described previ-
ously [12].
Myotoxic injury
Twelve-week-old or 24-month-old male and female
SOCS3 MKO (SOCS3fl/fl MCK-Cre+) mice and their
littermate controls (SOCS3fl/fl MCK-Cre− mice) were
anesthetized with an intraperitoneal injection (i.p.) of
100 mg/kg ketamine (Ceva Animal Health Pty. Ltd.,
Glenorlie, NSW, Australia) and 10 mg/kg xylazine (ilium
xylazil-20; Troy Laboratories, Smithfield, NSW, Australia).
Once non-responsive to tactile stimuli, the right tibialis
anterior (TA) muscle was surgically exposed and injected
with 40 μl notexin (10 μg/ml saline; Latoxan, Valence,
France) to induce muscle fiber degeneration. After the
intramuscular injection, the skin incision was closed with
Michel clips (Aesculap, Tuttlingen, Germany), and the
mouse allowed to recover on a heating pad. In 12-week-
old mice, the right TA muscle was excised and weighed at
1, 2, 3, 5, 7, or 14 days post-notexin injury. In 24-month-
old mice, the right TA muscle was excised and weighed at
7 days post-notexin injury only. The right TA muscles
were also excised from uninjured mice for use as controls.
The right TA was cut transversely with one third immedi-
ately snap frozen in liquid nitrogen for RNA extraction
and the remaining two thirds coated with optimal cutting
temperature (OCT) compound (Tissue-Tek, Sakura
Finetek, CA, USA) and frozen in thawing isopentane for
histological analyses and western immunoblotting. All
muscles were subsequently stored at −80 °C.
Assessment of contractile properties of skeletal muscle
and tissue collection
At 7 days post-notexin injury, both injured and uninjured
mice were anesthetized with sodium pentobarbitone
(Nembutal; 60 mg/kg; Sigma-Aldrich) via i.p. injection.
The methods for assessment of the contractile properties
of the mouse tibialis anterior muscle in situ have been
described in detail previously [31]. At the conclusion of
the contractile measurements in situ, the right and left TA
muscles were carefully excised, blotted on filter paper,
weighed on an analytical balance, and frozen in thawing
isopentane for later histological examination.
Skeletal muscle histology
Serial sections (5 μm) were cut transversely through the
TA muscle using a refrigerated (−20 °C) cryostat (CTI
Cryostat; IEC, Needham Heights, MA). Sections were
stained (or reacted) with hematoxylin and eosin (H&E)
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to determine general muscle architecture, an anti-
laminin antibody (#L9393; Sigma-Aldrich, St. Louis,
MO, USA) for determination of mean myofiber CSA, or
succinate dehydrogenase (SDH) to determine activity of
oxidative enzymes [32]. Optical density (OD) of SDH
was determined after 6 min of reactivity for all samples,
and SDH-reacted sections were captured in full color
using bright-field light microscopy and analyzed, as
described previously [31]. For histological assessments
and analysis of right TA muscle CSA in aged mice,
comparisons were made to a small number of older
uninjured control and SOCS3 MKO mice aged between
17 and 24 months of age (n = 5/genotype). Digital images
of stained sections were obtained using an upright
microscope with camera (Axio Imager day 1, Carl Zeiss,
Wrek, Göttingen, Germany), controlled by AxioVision
AC software (AxioVision AC Rel. 4.8, Carl Zeiss Imaging
Solutions, Wrek, Göttingen, Germany). Images were
quantified using AxioVision 4.8.2 software.
Skeletal muscle immunostaining
Serial sections (5 μm) were cut transversely through the
TA muscle using a refrigerated (−20 °C) cryostat (CTI
Cryostat; IEC, Needham Heights, MA). Sections were
fixed for 10 min in methanol at −20 °C, air-dried, and
subsequently incubated with Alexa488- and Alexa647-
conjugated antibodies raised against F4/80 and CD68
(Abcam., Cambridge, UK), respectively, for 1 h at room
temperature in a humidified chamber. Slides were rinsed
for 5 min in PBS containing 0.05 % Tween20 (PBStw) and
2 × 5 min in PBS and then incubated for 30 min with 4′,6-
diamindino-2-phenylindole (DAPI, 5 μg/mL PBS) to
visualize nuclei. After washing with PBStw and PBS, the
sections were embedded in Mowiol® and covered with a
coverslip. Digital images of stained sections were obtained
using an upright microscope with camera (Axio Imager
D1, Carl Zeiss, Wrek Göttingen, Germany), controlled by
AxioVision AC software (AxioVision AC Rel. 4.8.2, Carl
Zeiss Imaging Solutions, Wrek, Wrek Göttingen, Germany)
as described previously.
RNA extraction and qPCR
Total RNA was extracted from each portion of right TA
muscle (n = 6/genotype/time-point) using an RNeasy
Fibrous Tissue Mini Kit (Qiagen, Venlo, Limburg,
Netherlands) as per manufacturer’s instructions. The
concentration and quality of RNA samples was deter-
mined using Nanodrop 2000 spectrophotometer (Thermo
Scientific, Waltham, MA, USA). Real-time RT-PCR was
performed as described previously [30] using the following
forward and reverse primer sequences: MCK, 5′-CACCA
TGCCGTTCGGCAACA-3′ and 5′-GGTTGTCCACC
CCAGTCT-3′; SOCS3, 5′-GCTGGCCAAAGAAATAACC













ATC-3′ and 5′-ATTGTATTCCACCGCCATGT-3′. Gene
expression was quantified using a cycle threshold (CT)
method. As myotoxic injury with notexin causes complete
degradation of skeletal muscle fibers, normalizing mRNA
to a housekeeping gene is difficult, and so relative gene ex-
pression was calculated using the expression 2−ΔCT, nor-
malized to total cDNA content as determined using Qubit
2.0 Fluorimeter (Life Technologies, Carlsbad, CA, USA),
as described previously [12].
Antibodies
The following primary antibodies were used throughout
the experiments in 5 % BSA/TBS/0.1 % Tween-20:
rabbit-anti-phosphorylated STAT1 (Y701) (Cell Signaling
Technology, Danvers, MA, USA; 1:1000), mouse-anti-
STAT1 (BD Biosciences, San Jose, CA, USA; 1:1000),
rabbit-anti-phosphorylated STAT3 (Y705) (Cell Signaling
Technology, 1:1000), rabbit-anti-STAT3 (Cell Signaling
Technology, 1:1000), and rabbit-anti-SOCS3 (Immuno-
biological Laboratories Co. Ltd., Gunma, Japan; 1:200).
Horseradish peroxidase (HRP)-conjugated donkey-anti-
rabbit immunoglobulin (GE healthcare life sciences;
Marlborough, MA, USA) secondary antibody was used
at 1:5000 in 5 % BSA/TBS/0.1 % Tween-20. HRP-
conjugated sheep-anti-mouse immunoglobulin (GE Health-
care Life Sciences) secondary antibody was used at 1:5000
in 5 % BSA/TBS/0.1 % Tween-20.
Western immunoblotting
For protein analysis from C2C12 cells, media was aspirated
at the conclusion of treatment and attached cells were lysed
directly in the plate on ice in cold RIPA buffer (50 mM
Tris–HCl, 150 mM NaCl, 1 mM EDTA, 1 % Triton X-100,
1 % Na-Deoxycholate, 0.1 % SDS, protease inhibitor cock-
tail) for 10 min. Lysates were collected into Eppendorf
tubes and diluted in 4× Lammeli sample buffer (0.25 M
Tris-HCl, pH6.8, 6 % SDS, 40 % glycerol, 0.04 % bromo-
phenol blue, 16 % DTT), run on 4–15 % Criterion TGX
Stain-Free gels (Bio-Rad Laboratories, Gladesville, NSW,
Australia) at a constant voltage of 100 V and transferred
to PVDF membranes by wet transfer.
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For protein analysis from muscle tissues, the remaining
OCT embedded right TA muscle was excised from the
OCT media with a razor blade following sectioning. Ex-
cised muscles were homogenized in metal bead-containing
matrix tubes in cold RIPA buffer (50 mM Tris-HCl,
150 mM NaCl, 1 mM EDTA, 1 % Triton X-100, 1 %
Na-Deoxycholate, 0.1 % SDS, protease inhibitor cocktail)
using a Precellys24 automated homogenizer. Homogenized
muscle samples were diluted in 3× SDS loading buffer
(125 mM Tris-HCl, 4 M urea, 10 % glycerol, 4 % SDS, 10 %
β-ME, and 0.001 % bromophenol blue) according to muscle
wet concentration and run on 4–15 % Criterion TGX
Stain-Free gels (Bio-Rad Laboratories) at a constant voltage
of 200 V and transferred to PVDF membranes using the
Trans-Blot Turbo system (Bio-Rad Laboratories).
Membranes were blocked in 5 % BSA in TBST and in-
cubated at 4 °C overnight in primary antibody solutions.
Horseradish peroxidase (HRP)-conjugated secondary
antibodies were applied for 1 h at RT. Membranes were
visualized with ECL (SuperSignal West Femto Chemilu-
minescent Substrate, Thermo Scientific Pierce, IL, USA)
and imaged using ChemiDoc MP Imaging System. A
stain-free image of each gel was acquired prior to trans-
fer. ECL and stain-free images were quantified using
Image Lab 4.1 software (Bio-Rad Laboratories). The
intensity of each protein of interest was normalized to
the total protein content of the sample as determined
from the stain-free image as described previously [33].
Statistical analyses
For in vitro studies, data were analyzed between groups
using a one-way analysis of variance (ANOVA) with a
Fisher’s LSD post hoc multiple comparisons test for
comparison to untreated cells. For all in vivo work, data
were analyzed between groups for the effect of genotype
and time using a two-way ANOVA with Fisher’s LSD
post hoc multiple comparisons test used to detect sig-
nificant differences between means where appropriate. A
P value less than 0.05 was considered statistically signifi-
cant. All statistical analyses were carried out using Prism
Graphpad 6 software (GraphPad Software Inc., La Jolla,
CA, USA). All values are presented as mean ± standard
error of mean (SEM).
Results
Inflammatory cytokines induce JAK/STAT signaling and
SOCS3 protein in myoblasts and myotubes in vitro
The pro-inflammatory cytokines IL-6, IFN-γ, and TNF-α
induce JAK/STAT signaling and are expressed at high
levels after myotoxic injury [34–36]. The signaling path-
ways induced by these cytokines specifically within
muscle cells were examined in C2C12 myoblasts and
myotubes in vitro. While no STAT3 phosphorylation
was observed in unstimulated C2C12 myoblasts (0 h), a
low basal level of phosphorylated STAT3 was present in
unstimulated C2C12 myotubes (0 h; Fig. 1a). Addition of
rm IL-6 (100 ng/mL) significantly increased STAT3
phosphorylation after 15 min stimulation in both myo-
blasts and myotubes which decreased at 1 h stimulation
(Fig. 1a). In comparison, stimulation with rm IFN-γ
(100 ng/mL) induced very low levels of STAT3 phos-
phorylation in both myoblasts and myotubes, and rm
TNF-α stimulation (10 ng/mL) did not induce phos-
phorylation of STAT3 in either cell population (Fig. 1a).
Phosphorylation of STAT1 occurred within 15 min and
up to 4 h of stimulation with rm IFN-γ in C2C12 myo-
blasts and to a lesser extent in C2C12 myotubes (Fig. 1b).
No significant STAT1 phosphorylation was observed fol-
lowing rm IL-6 or rm TNF-α stimulation in either cell
type (Fig. 1b).
STAT3 dimerizes after phosphorylation and translo-
cates to the nucleus where it regulates the transcription
of many genes, including SOCS3, which in turn nega-
tively regulates the activation of STAT3 [37]. SOCS3
protein was increased after 30 min and 1 h of rm IL-6
stimulation, but not rm IFN-γ or rm TNF-α stimulation,
in myoblasts or myotubes (Fig. 1c). Together, these data
demonstrate that inflammatory cytokines, particularly
IL-6, activate signaling pathways directly within skeletal
muscle cells, resulting in production of SOCS3 protein.
SOCS3 deletion specifically within mature muscle fibers does
not alter the regenerative response after myotoxic injury
As our in vitro data demonstrated that JAK/STAT sig-
naling induced SOCS3 protein expression in both skel-
etal muscle myoblasts and mature myotubes, we utilized
the SOCS3fl/fl MCK-Cre mouse, in which the Socs3 gene
is deleted only in cells expressing muscle creatine kinase
(MCK), to determine whether absence of SOCS3 in ma-
ture skeletal muscle fibers impairs muscle fiber regener-
ation. The specificity of the MCK-Cre mediated SOCS3
deletion was confirmed by genomic PCR which showed
the presence of the 288 bp deleted SOCS3 fragment in
skeletal muscles but not livers of SOCS3 MKO mice
(Additional file 1: Figure S1A, B) and by qPCR which
demonstrated a lipopolysaccharide (LPS)-induced in-
crease in Socs3 gene expression in isolated fibers from
freeze-dried gastrocnemius muscles from control but
not SOCS3 MKO mice (Additional file 1: Figure S1C).
To determine the time-points after myotoxic injury in
which SOCS3 deletion would be expected, we examined
the gene expression of MCK. In both control and SOCS3
MKO mice, MCK gene expression was detected in unin-
jured muscle (UN), decreased at day 1, day 2, and day 3
and subsequently increased progressively from day 5 to
day 14 post-notexin injury (Fig. 2a; P < 0.0001 injury
main effect). However, MCK expression was lower in
uninjured muscles from SOCS3 MKO mice relative to

















Fig. 1 (See legend on next page.)
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control (Fig. 2a; **P < 0.01). Socs3 gene expression was
detected at low levels in uninjured muscles and was not
different between muscles from control and SOCS3
MKO mice (Fig. 2b). In control mice, Socs3 gene expres-
sion increased at day 1 post-notexin injury and de-
creased progressively to basal levels by day 14 (Fig. 2b;
P < 0.0001 injury main effect). The increase in Socs3 gene
expression after notexin injury was delayed in muscles
from SOCS3 MKO mice, being lower at day 1 (**P < 0.01)
and higher at day 2 (*P < 0.05) compared to control but
decreased to basal levels by day 14 (Fig. 2b; P < 0.0001
injury main effect). Therefore, deletion of Socs3 in MCK-
expressing mature muscle fibers alters the expression pro-
file of the Socs3 gene after myotoxic injury.
To examine the progression of muscle regeneration
post-injury, we analyzed the gene expression of the
muscle stem cell marker, Pax7 (Fig. 2c), the master myo-
genic regulator, MyoD (Fig. 2d), and the marker of early
muscle cell differentiation, Myogenin (Fig. 2e). In mus-
cles from both control and SOCS3 MKO mice, the
expression of all three markers was low in uninjured
muscles and at day 1 and day 2 post-notexin injury,
(See figure on previous page.)
Fig. 1 IL-6 and IFN-γ stimulation initiate JAK/STAT signaling in C2C12 myoblasts and myotubes in vitro. C2C12 proliferating myoblasts (left) or
differentiated day 5 myotubes (right) either remained unstimulated (0) or were incubated with 100 ng/mL rmIL-6, 100 ng/mL rmIFN-γ, or 10 ng/
mL rmTNF-α for 0.25, 0.5, 1, 2, or 4 h at 37 °C + 5 % CO2. At the conclusion of stimulation, cells were lyzed and subject to SDS-PAGE and western
immunoblotting for either pSTAT3/STAT3 (a), pSTAT1/STAT1 (b), or SOCS3 and total protein (TPS; c). Representative immunoblots are shown for
each probe with n = 1 per time-point. Three individual experiments were performed, and bands were quantified to produce the graphs shown.
Data are expressed as mean ± SEM. Statistical analysis was performed using a one-way ANOVA with a Fisher’s LSD post hoc multiple comparisons






Fig. 2 SOCS3 deletion in mature myofibers in vivo does not alter regeneration after myotoxic injury. Control (SOCS3fl/fl MCK-Cre−) and SOCS3
MKO (SOCS3fl/fl MCK-Cre+) mice were either left uninjured (UN) or received a single 40 μL injection of notexin (10 μg/ml) into the right TA muscle
and were killed for analysis at 1 day (D1), 2 days (D2), 3 days (D3), 5 days (D5), 7 days (D7), or 14 days (D14) post-notexin injury. qRT-PCR using
primers to detect MCK (a), Socs3 (b), Pax7 (c), MyoD (d), and Myogenin (e) was performed on RNA extracted from snap frozen muscles following
dissection. Data are expressed as mean ± SEM. Statistical analysis was performed using a two-way ANOVA with a Fisher’s LSD post hoc multiple
comparisons test to determine the effects of genotype and time. n = 8 mice/time-point/genotype. *P < 0.05, **P < 0.01 compared to control
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peaked at day 3, and subsequently decreased to basal
levels by day 14 (Fig. 2c–e; P < 0.001 injury main
effect). While MyoD expression was decreased slightly
at day 3 post-notexin injury in muscles from SOCS3
MKO mice relative to control (Fig. 2d; *P < 0.05), the
time-course of Pax7, MyoD, and Myogenin gene
expression did not vary compared with control indi-
cating that regeneration was not altered by muscle
fiber-specific SOCS3 deletion.
Loss of SOCS3 in skeletal muscle fibers increases the early
inflammatory response after myotoxic injury
We examined the effect of SOCS3 deletion on the acti-
vation of JAK/STAT signaling during regeneration after
myotoxic injury. No phosphorylation of JAK1, JAK2,
STAT1, or STAT5 was detected in muscle lysates from
uninjured control or SOCS3 MKO mice (data not
shown). In control and SOCS3 MKO mice, STAT3 phos-
phorylation was not detected in uninjured muscles but
was increased at day 1 post-notexin injury and remained
constant at days 2, 3, and 5 then decreased to basal
levels by day 7 (Fig. 3a; P < 0.0001 injury main effect). In
muscles from SOCS3 MKO mice, STAT3 phosphoryl-
ation was significantly increased compared to muscles
from control mice at day 1 post-notexin injury (Fig. 3a;
**P < 0.01 compared to control).
As increased STAT3 phosphorylation is an indicator of
an increased inflammatory response, we next examined
the presence of inflammatory cells and the gene expres-
sion of inflammatory markers. Immunostaining for the
inflammatory cell markers F4/80 (Fig. 3b) and CD68
(Fig. 3c) showed increased presence of these cells at D2
and D3 following injury in muscles from control and
SOCS3 MKO mice and indicated an increased infiltra-
tion of inflammatory cells at D2 following injury in mus-
cles from SOCS3 MKO mice compared to control
(Fig. 3b, c). The inflammatory cytokine IL-6 gene was
expressed at low levels in uninjured muscles, highly
expressed at day 1 and day 2 post-injury and decreased
to basal levels by day 14 (Fig. 3d; P < 0.0001 injury main
effect). Gene expression of IFN-γ increased around day
3 post-notexin injury and was barely detected by day 14
(Fig. 3e; P < 0.01 injury main effect). SOCS3 deletion had
no effect on IL-6 (Fig. 3d) or IFN-γ (Fig. 3e) expression
after myotoxic injury.
The gene expression of the pro-inflammatory cytokine
TNF-α, as well as the inflammatory cell markers F4/80
and CD68, was low in uninjured muscles from control
and SOCS3 MKO mice, increased progressively to day 3,
then reduced to basal levels by day 14 post-notexin in-
jury (Fig. 3f–h; P < 0.0001 time main effect). In muscles
from SOCS3 MKO mice, TNF-α, F4/80 and CD68 gene
expression was higher compared to muscles from
control mice at day 2 post-notexin injury (Fig. 3f–h;
****P < 0.0001, **P < 0.01, ***P < 0.001, respectively).
Together, these results suggest that muscle fiber-specific
SOCS3 deletion increases the inflammatory signal at
day 1, resulting in an enhanced inflammatory response at
day 2, which appears resolved by day 3 post-notexin injury.
Skeletal muscle fiber-specific deletion of SOCS3 does not
alter force production before or after myotoxic injury
To determine whether an enhanced early inflammatory
response after myotoxic injury in muscles lacking
SOCS3 had any effect on muscle function, we next ex-
amined mass and force production of uninjured and
notexin-injured TA muscles from control and SOCS3
MKO mice. Histology of uninjured muscles from aged
control and SOCS3 MKO mice appeared normal and
ongoing repair was observed in injured muscles as indi-
cated by the continued presence of centrally-nucleated
fibers, which looked similar in SOCS3 MKO muscles
(Fig. 4a, b). Skeletal muscle-specific deletion of SOCS3
did not affect the mass of the uninjured right TA muscle
or at 7 days post-notexin injury, but control and SOCS3
MKO muscles were smaller after notexin injury (Fig. 4c;
P < 0.01 injury main effect). Similarly, average muscle
fiber cross-sectional area (CSA) was reduced at 7 days
post-injury compared with uninjured muscles and was
not changed with SOCS3 deletion (Fig. 4d; P < 0.0001 in-
jury main effect). Both maximum isometric force and
specific force were reduced 7 days after notexin injury
compared with uninjured muscles and were similarly
not affected by SOCS3 deletion (Fig. 4e, f; P < 0.0001
injury main effect). SOCS3 deletion did not affect force
production at any stimulation frequency in either the
uninjured muscles (Additional file 2: Figure S2A) or in
muscles at 7 days post-injury (Additional file 2: Figure
S2B). Notexin injury reduced force production during a
4-min fatiguing protocol in control mice (Fig. 4g; P < 0.05
compared with uninjured muscles), but there was no dif-
ference in the fatigue response between uninjured and in-
jured muscles of SOCS3 MKO mice (Fig. 4h). Analysis of
force production over the 4-min fatiguing protocol
between uninjured muscles from control and SOCS3
MKO mice showed this difference to be due to an in-
creased fatigue response in the uninjured muscles of
SOCS3 MKO mice (Fig. 4i; *P < 0.05 compared to
control). Gene expression analysis showed no signifi-
cant change in expression of myosin heavy chain
isoforms MyHCIIb (Additional file 3: Figure S3A),
MyHCIIx (Additional file 3: Figure S3B), MyHCI
(Additional file 3: Figure S3C), or MyHCIIa in
muscles from SOCS3 MKO mice (Additional file 3:
Figure S3D), and oxidative capacity of muscles from
SOCS3 MKO was unchanged compared to control
(Additional file 3: Figure S3E).
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Fig. 3 Loss of SOCS3 in mature myofibers in vivo enhances the inflammatory response after myotoxic injury. Control (SOCS3fl/fl MCK-Cre−) and SOCS3
MKO (SOCS3fl/fl MCK-Cre+) mice were either left uninjured (UN) or received a single 40 μL injection of notexin (10 μg/ml) into the right TA muscle and
then killed for analysis at 1 day (D1), 2 days (D2), 3 days (D3), 5 days (D5), 7 days (D7), or 14 days (D14) post-notexin injury. a Western immunoblotting
for phosphorylated and total STAT3 protein levels was performed on protein extracted from remaining OCT embedded muscles following tissue
sectioning. Representative immunoblots for phosphorylated (top) and total (bottom) STAT3 protein levels are shown. Band intensity was quantified
using ImageQuant software (Bio-Rad Laboratories) and the ratio of phosphorylated/total STAT3 protein levels was determined. b Representative
sections immunostained with F4/80 (green) and DAPI (blue) of the TA muscle from uninjured or day 1, 2, 3, 5, 7, or 14 injured control and SOCS3 MKO
mice. c Representative sections immunostained with CD68 (red) and DAPI (blue) of the TA muscle from uninjured or day 1, 2, 3, 5, 7, or 14 injured
control and SOCS3 MKO mice. qRT-PCR using primers to detect IL-6 (d), IFN-γ (e), TNF-α (f), F4/80 (g), and CD68 (h) was performed on RNA extracted
from snap frozen muscles following dissection. Data are expressed as mean ± SEM. Statistical analysis was performed using a two-way ANOVA with a
Fisher’s LSD post hoc multiple comparisons test to determine the effects of genotype and time. n= 8 mice/time-point/genotype. **P< 0.01, ***P< 0.001,
****P< 0.0001 compared to control. Scale bar= 50 μm












Fig. 4 (See legend on next page.)
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Loss of SOCS3 does not alter regeneration or
inflammation after myotoxic injury in aged mice
As skeletal muscle-specific SOCS3 deletion models reduced
SOCS3 levels and lower SOCS3 levels have been reported
in muscles from aged mice [29], we next examined whether
loss of SOCS3 in skeletal muscles impacted on muscle re-
generation in aged (24 month old) mice. Notexin injuries
were performed on 24-month-old control and SOCS3
MKO mice (n = 7–8/genotype) and markers of regener-
ation and inflammation were assessed in the injured mus-
cles at 7 days post-injury. Histology of uninjured muscles
from aged control and SOCS3 MKO mice appeared nor-
mal, but consistent with previous reports, ongoing inflam-
mation and repair was observed in injured 24-month-old
control muscles, which looked similar in SOCS3 MKO
muscles (Fig. 5a). At 7 days post-notexin injury, SOCS3 de-
letion did not alter TA mass relative to body mass (Fig. 5b),
and while muscle fiber CSA was significantly smaller in in-
jured muscles, SOCS3 deletion had no further effect (Fig. 5c;
****P < 0.0001 injury main effect).
Western immunoblotting revealed no difference in
STAT3 phosphorylation in SOCS3 MKO muscles com-
pared to control (Fig. 5d), and no change was observed
in Socs3 RNA levels between control and SOCS3 MKO
mice at 7 days post-notexin injury, likely due to the con-
tinued expression of Socs3 by muscle resident cells other
than the myofibers (Fig. 5e). While no significant
changes were observed, gene expression levels of the in-
flammatory cytokines IL-6 (Fig. 5f; P = 0.05) and TNF-α
(Fig. 5g; P = 0.1) but not IFN-γ (Fig. 5h; P = 0.84) or the
inflammatory cell markers F4/80 (Fig. 5i; P = 0.19) or
CD68 (Fig. 5j; P = 0.16) tended to be increased in mus-
cles from SOCS3 MKO mice compared to control at
7 days post-notexin injury. Similarly, gene expression
levels of the myogenic markers Pax7 (Fig. 5k; P = 0.15),
MyoD (Fig. 5l; P = 0.28), and Myogenin (Fig. 5m; P = 0.21)
were not changed in muscles of SOCS3 MKO mice
compared with control at 7 days post-injury.
Discussion
SOCS3 RNA and/or protein levels are altered in muscles
with aging [27–29] and may be implicated in impaired
muscle regeneration with aging; but whether they in-
crease or decrease remains to be determined. SOCS3 is
expressed by multiple cell types in regenerating skeletal
muscles, but the relative contribution of SOCS3 within
each cell type to altered muscle inflammation and regen-
eration is unknown. Using mice specifically lacking
SOCS3 in MCK-expressing mature muscle fibers, we
have shown that although reduced SOCS3 expression
increases the early inflammatory response in skeletal
muscle after myotoxic injury, this does not impact
regeneration.
SOCS3 MKO mice undergo normal muscle develop-
ment and exhibit improved insulin sensitivity when fed a
high fat diet compared to control mice [26]. Consistent
with these findings, we observed no significant changes
in muscle structure and function between injured and
uninjured muscles of control and SOCS3 MKO mice.
However, uninjured TA muscles from SOCS3 MKO
mice were more susceptible to fatigue than muscles
from control mice, in the absence of any changes in oxi-
dative capacity or MyHC isoform gene expression.
Treadmill running performance was unchanged between
control and SOCS3 MKO mice [26], indicating that
while muscle fiber-specific SOCS3 deletion increased
fatigue in contracting TA muscles, overall exercise cap-
acity was unaffected.
JAK/STAT signaling is intact in C2C12 cells in vitro,
with addition of leukemia inhibitory factor (LIF), basic
fibroblast growth factor (bFGF), growth hormone (GH),
and leptin or insulin-like growth factor (IGF) all activat-
ing STAT3 [38–41]. The time-course of activation of
STAT3 and induction of SOCS3 following addition of
IL-6 to C2C12 cells was consistent with previous
observations of the IL-6 family cytokine, LIF, in mouse
embryonic stem (ES) cells, and the related cytokine
granulocyte colony stimulating factor (G-CSF) in
isolated mouse bone marrow cells [14, 42], indicating
that muscle cells employ similar JAK/STAT signaling
mechanisms to these other cell types. TNF-α and IFN-γ
directly upregulate SOCS3 expression in hematopoietic
cells and liver [37, 43–45], but we were unable to detect
SOCS3 expression in C2C12 cells following stimulation
(See figure on previous page.)
Fig. 4 Skeletal muscle fiber-specific deletion of SOCS3 does not alter force production of the TA muscles. Control (SOCS3fl/fl MCK-Cre−) and SOCS3
MKO (SOCS3fl/fl MCK-Cre+) mice were either left uninjured (UN) or received a single 40 μL injection of notexin (10 μg/ml) into the right TA muscle.
Representative hematoxylin and eosin (a) and laminin and DAPI (b) stained sections of TA muscle from uninjured or day 7 injured control and
SOCS3 MKO mice. Muscle mass relative to the uninjured left TA muscle (c), muscle fiber size (d), maximum isometric force (e), and specific
(normalized) force (f) were determined at day 7 post-notexin injury. Data are expressed as mean ± SEM. Statistical analysis was performed
using a two-way ANOVA with a Fisher’s LSD post hoc multiple comparisons test to determine effects of genotype and time. n = 8 mice/
time-point/genotype. **P < 0.01, ***P < 0.001, ****P < 0.0001 compared to uninjured muscle. Specific force production during a 4-min fa-
tiguing protocol comparing uninjured and day 7 injured right TA muscles from control mice (g), SOCS3 MKO mice (h), and comparing
uninjured control and SOCS3 MKO mice separately (i). Data are expressed as mean ± SEM. Statistical analysis was performed using a re-
peated measures two-way ANOVA with a Fisher’s LSD post hoc multiple comparisons test to determine effects of genotype and time. n
= 8 mice/time-point/genotype. *P < 0.05 compared to uninjured muscle from control mice. Scale bar = 50 μm
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with either IFN-γ or TNF-α. Endogenous SOCS3 protein
expression is generally quite low and difficult to detect
[46]. Therefore, if addition of TNF-α or IFN-γ did
increase SOCS3 protein expression in C2C12 cells, this
was below the level of detection and not to the level
induced by IL-6 stimulation.
SOCS3 is a critical regulator of inflammatory signaling
in many cell types. Conditional ablation of SOCS3 in
various tissues, including hematopoietic cells and liver
causes enhanced inflammation and emergency granulo-
poiesis [16, 17, 47–49]. Therefore, our observation of an
increased inflammatory response after myotoxic damage
in SOCS3 MKO mice was not unexpected. Increased in-
flammation could impact regeneration, but we observed
no change in the regenerative capacity of muscles from
SOCS3 MKO mice compared with control, likely be-
cause of the rapid resolution of the increased inflamma-
tory cell infiltrate by D3 after injury.
SOCS3 is present in mature muscle fibers but also
expressed in both muscle stem cells and inflammatory
cells which are critical for successful muscle regener-
ation. We observed Socs3 gene expression at varying
levels after myotoxic injury in SOCS3 MKO mice indi-
cating that SOCS3-expressing cells (most likely a com-
bination of these two cell types) were present in the
muscle at these times. SOCS3 expression is critical for
the proper regulation of inflammatory cell function in
multiple states of inflammation [14–17, 47, 48], and
regulation of JAK/STAT signaling is critical to skeletal
muscle stem cell function. Microarray studies have
shown reduced Socs3 gene expression upon muscle stem
cell activation [19]. Furthermore, increased STAT3 acti-
vation has been reported in muscle stem cells isolated
from muscles of old mice compared with those from
younger mice [50] and reduction of STAT3 activation by
either conditional ablation or transient pharmacologic
inhibition modulates the proliferative and differentiation
potential of the muscle stem cell pool [50, 51]. There-
fore, SOCS3 expression and function is likely critical in
the regulation of both the inflammatory response and
muscle stem cell function in the context of muscle
injury. We had hypothesized that reduced SOCS3 ex-
pression or function contributed to age-related impair-
ments in muscle regeneration, but since regeneration
was not impaired in SOCS3 MKO mice, reduced SOCS3
expression or function within the mature muscle fiber is
unlikely to contribute directly. It remains possible that
reduced SOCS3 protein expression within the muscle
stem cell pool and/or inflammatory cells might impair
the injury-repair process.
Conclusions
Specific deletion of SOCS3 within MCK-expressing
muscle fibers, which models the reduced SOCS3 expres-
sion thought to occur in muscles with aging, enhanced
the early inflammatory response but ultimately did not
affect muscle regeneration after myotoxic injury.
Furthermore, inflammation and muscle regeneration
were not altered after myotoxic injury in the muscles of
24-month-old SOCS3 MKO mice compared with con-
trol. Therefore, reduced SOCS3 expression/function
within the muscle fiber is likely not a contributing factor
to age-related impairments in muscle regeneration.
However, since SOCS3 is expressed in other muscle resi-
dent cells, including hematopoietic cells and muscle
stem cells, it remains possible that the expression level
and/or function of SOCS3 may be altered in these popu-
lations with age. Further studies examining the effect of
SOCS3 deletion in these populations on muscle regener-
ation are warranted.
Additional files
Additional file 1: Figure S1. Genomic PCR to confirm correct Socs3
deletion. (A) Schematic of Socs3 gene demonstrating floxed regions
(LoxP) flanking exon 2 and location of the sequencing primers both prior
to and post-Cre excision. (B) Genomic PCR using the primers shown in
(A) confirmed the presence of the 288 bp deleted DNA band in muscle
but not liver of SOCS3fl/fl MCK-Cre positive and not SOCS3fl/fl MCK-Cre-negative
mice. (C) qRT-PCR using primers to detect Socs3 gene expression in RNA
extracted from muscle fibers isolated from freeze-dried gastrocnemius muscles
of saline or LPS-injected control and SOCS3 MKO mice. Data are expressed as
mean ± SEM and compared with a two-way ANOVA and Fisher’s LSD post hoc
multiple comparisons test to determine the effect of genotype and LPS
(See figure on previous page.)
Fig. 5 SOCS3 deletion does not alter regeneration or inflammation after myotoxic injury in aged mice. Twenty-four-month-old control (SOCS3fl/fl
MCK-Cre−) and SOCS3 MKO (SOCS3fl/fl MCK-Cre+) mice were either left uninjured (UN) or received a single 40 μL injection of notexin (10 μg/ml)
into the right TA muscle. a Representative hematoxylin and eosin-stained sections of the TA muscle from uninjured or day 7 injured control and
SOCS3 MKO mice. Muscle mass relative to body mass (b) and muscle fiber size (c) was determined at day 7 post-notexin injury. d Western
immunoblotting for phosphorylated and total STAT3 protein levels was performed on protein extracted from the remaining OCT embedded
muscles following tissue sectioning. Representative immunoblots for phosphorylated (top) and total (bottom) STAT3 protein levels are shown.
Band intensity was quantified using ImageQuant software (Bio-Rad Laboratories), and the ratio of phosphorylated/total STAT3 protein levels was
determined. Bands used for quantification are indicated by arrows. qRT-PCR using primers to detect Socs3 (e), IL-6 (f), TNF-α (g), IFN-γ (h), F4/80 (i),
CD68 (j), Pax7 (k), MyoD (l), or Myogenin (m) was performed on RNA extracted from snap frozen muscles following dissection. Data are expressed
as mean ± SEM. Statistical analysis was performed using an unpaired two-tailed Student’s t test (n = 7–8 mice/time-point/genotype) except for
analysis of muscle fiber size (c) which was analyzed with a two-way ANOVA and Fisher’s LSD post hoc multiple comparisons test to determine
the effect of genotype and injury (n = 4–8 mice/time-point/genotype). Scale bar = 100 μm
Swiderski et al. Skeletal Muscle  (2016) 6:36 Page 13 of 15
injection (n= 2 mice/genotype). ***P< 0.001 compared to uninjured muscle
from control mice. (PDF 115 kb)
Additional file 2: Figure S2. Frequency-force relationships for uninjured
and day 7 (D7) notexin-injured muscles from control and SOCS3 MKO mice.
Frequency-force relations for specific (normalized) force at different stimulation
frequencies (10–200 Hz) in muscles of either uninjured (A) or day 7 post-
notexin-injured (B) control or SOCS3 MKO mice. Data are expressed
as mean ± SEM. Comparisons were made using a two-way repeated
measures ANOVA with Fisher’s LSD multiple comparisons test post hoc to
determine the effect of genotype and stimulation frequency. n = 8 mice/
genotype. (PDF 99 kb)
Additional file 3: Figure S3. Myosin heavy chain gene expression and
muscle fiber oxidative capacity in muscles from uninjured control and
SOCS3 MKO mice. qRT-PCR using primers to detect MyHCIIb (A), MyHCIIx
(B), MyHCI (C), and MyHCIIa (D) was performed on RNA extracted from
snap frozen muscles following dissection. Data are expressed as mean ±
SEM and compared with an unpaired two-tailed Student’s t test. n = 8
mice/genotype. (E) Representative succinate dehydrogenase (SDH)-reacted
TA muscle sections from uninjured muscles of 12-week-old control and
SOCS3 MKO mice. Quantification of SDH intensity was determined by
analysis of SDH reacted TA muscle sections. Data are expressed as mean ±
SEM and compared with an unpaired two-tailed Student’s t test. n = 5 mice/
genotype. Scale bar = 100 μm. (PDF 145 kb)
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